Arteriovenous graft thrombosis – Basic Information

Go back

Arteriovenous graft thrombosis is a serious complication that affects people who depend on hemodialysis for kidney failure. When blood clots block the artificial vessel connection used for dialysis, patients may miss vital treatment sessions and face the risk of losing their access permanently. Understanding this condition helps patients and their families recognize warning signs early and seek timely care.

Epidemiology

More than 400,000 people in the United States rely on hemodialysis to survive kidney failure each year. These individuals need a functioning vascular access—a connection between an artery and vein—to allow blood to flow through a dialysis machine. While there are three types of access available (catheters, arteriovenous fistulas, and arteriovenous grafts), each comes with its own set of challenges.[5][6][11]

Arteriovenous grafts are artificial tubes, usually made from a synthetic material called polytetrafluoroethylene, which is placed under the skin to connect an artery and a vein. These grafts are commonly used when a patient’s own veins are not suitable for creating a direct connection. The problem with arteriovenous grafts is that they clot much more frequently than natural fistulas. Studies show that graft thrombosis happens approximately 0.5 to 2.0 times per year for each patient, compared to only 0.1 to 0.5 times per year for arteriovenous fistulas.[5][12]

The statistics are sobering. As many as 25% of hospital admissions for dialysis patients are directly related to problems with their vascular access, including thrombosis and malfunction. Even more concerning is that access thrombosis accounts for 65 to 85% of all cases where the access is permanently lost, forcing patients to start over with a new access site or rely on temporary catheters.[5][11]

In the United States, despite efforts to increase the use of arteriovenous fistulas, which are generally safer and longer-lasting, approximately 83% of patients begin hemodialysis with a catheter rather than a fistula or graft. This means that many patients will eventually need a graft placed, putting them at risk for thrombosis-related complications.[11]

Causes

Arteriovenous graft thrombosis happens when blood inside the graft changes from a free-flowing liquid into a semi-solid gel, forming what doctors call a blood clot or thrombus. This transformation occurs when blood does not flow smoothly through the graft. The underlying problem is almost always narrowing of the blood vessels, a condition called stenosis, which slows down blood flow and creates conditions where clotting becomes likely.[3][9]

The narrowing that leads to graft thrombosis most commonly develops at specific locations. The connection point where the graft meets the vein, called the graft-to-vein anastomosis, is particularly vulnerable. This spot experiences dramatic changes in blood flow patterns, pressure, and speed. When the synthetic graft connects to the natural vein, the vein must suddenly handle much higher pressure and faster flow than it was designed for. This stress damages the inner lining of the vein, triggering the body’s repair mechanisms.[1][17]

The body responds to this damage by sending extra cells to repair the problem. However, these repair cells can accumulate over time, building up on the vessel walls in a process called intimal hyperplasia. This is the thickening of the innermost layer of the vein. As this layer grows thicker, the opening through which blood flows becomes narrower and narrower, eventually slowing blood flow to the point where clotting occurs.[17]

The quality of the blood vessels themselves plays a major role in whether stenosis and thrombosis develop. Patients with chronic kidney disease often have arteries that are narrowed or hardened by calcium deposits, especially if they also have diabetes or high blood pressure. These conditions are relatively common among dialysis patients. When the artery feeding blood into the graft is too narrow or stiff, it cannot provide adequate blood flow, which increases the risk of clotting inside the graft.[1]

Another important cause of stenosis is repeated trauma to the same areas of the graft. Each time needles are inserted for dialysis—which happens multiple times per week—small injuries occur. If needles are placed in the same spots repeatedly, scar tissue forms. This scar tissue can gradually narrow the graft or the veins connected to it. Similar damage can happen from repeated blood pressure measurements, blood draws, or intravenous line placements in the arm with the graft.[17]

⚠️ Important
Stenosis is responsible for approximately 78% of early arteriovenous graft failures and remains the most common cause of late graft failure after three months. When stenosis develops but goes unrecognized and untreated, it creates the perfect conditions for blood to clot, leading to complete blockage of the graft.

Risk Factors

Several patient characteristics and medical conditions increase the likelihood of developing graft thrombosis. People with diabetes face higher risk because diabetes damages blood vessels throughout the body, making them less flexible and more prone to narrowing. The same is true for patients with high blood pressure, which is both a cause and consequence of kidney disease. These two conditions often occur together in dialysis patients, compounding the risk.[1]

The quality and size of blood vessels available for creating the graft connection matter greatly. Surgeons prefer arteries that are at least 2.5 millimeters in diameter for graft placement, though skilled surgeons can work with vessels as small as 2 millimeters. Arteries that are smaller than this, or vessels that are stiff and calcified rather than soft and flexible, create less-than-ideal conditions for long-term graft function. Veins at the outflow end should ideally be at least 2.5 millimeters in diameter as well.[1]

Patients who have had previous access procedures or multiple central venous catheters placed in their neck or chest veins face additional challenges. These prior interventions can cause scarring or narrowing of the large veins that drain blood from the arm back to the heart. If the outflow pathway is compromised anywhere along its route—from the graft connection all the way to the right side of the heart—blood flow will be impaired, increasing thrombosis risk.[1]

Surgical technique and the angle at which the graft connects to the vein also influence outcomes. Research suggests that the angle of connection affects how smoothly blood flows from the graft into the vein. Very shallow angles (less than 20 degrees) and very steep angles (greater than 40 degrees) both create abnormal flow patterns that can damage vessel walls. Intermediate angles around 30 degrees appear to be optimal for reducing these harmful flow disturbances.[20]

Symptoms

Recognizing the warning signs of graft problems is crucial for preventing complete thrombosis. Many symptoms develop gradually as stenosis worsens over time. One of the earliest signs is a change in how the graft feels. Normally, when you place your fingers on the skin over a functioning graft, you should feel a gentle vibration caused by blood rushing through. This sensation is called a thrill. If the thrill becomes weak, changes in character, or disappears entirely, it suggests blood flow has decreased significantly.[12][13]

Listening to the graft with a stethoscope reveals another important clue. A healthy graft produces a continuous rushing sound called a bruit (pronounced “brew-ee”). When stenosis develops, this sound may become abnormally high-pitched, or it may lose its normal continuous quality throughout the heartbeat cycle. In cases of inflow problems, where the artery supplying blood to the graft is narrowed, the bruit may become weak or barely audible.[12][18]

Changes in how the graft looks can also signal trouble. If the graft becomes more visibly pulsatile—meaning you can see it pulsing with each heartbeat more than usual—this may indicate a blockage somewhere in the venous outflow. The opposite problem, a graft that appears flat or does not fill well, suggests inadequate arterial inflow. Some patients notice swelling in their hand or arm on the side with the graft, which can indicate outflow obstruction.[12]

During dialysis sessions, several problems may emerge that point to graft dysfunction. The dialysis staff may have difficulty inserting the needles into the access, or they may struggle to achieve adequate blood flow rates through the machine. Prolonged bleeding from the needle puncture sites after dialysis ends is another red flag. This happens because increased pressure builds up in the graft when outflow is obstructed, making it harder for blood clots to form at the puncture sites after needles are removed.[12]

Patients may experience pain or discomfort in the arm with the graft, particularly during dialysis. Some notice changes in the overall appearance of their access, such as the development of bulging areas or aneurysm-like dilations. These occur when weakened sections of the vessel wall balloon outward in response to increased pressure from downstream obstruction.[17]

When thrombosis actually occurs—meaning the graft becomes completely clotted—the symptoms are usually unmistakable. The thrill and bruit disappear entirely. The graft may feel firm or rope-like rather than soft and pulsatile. The arm may become swollen, and dialysis cannot be performed through the access. This is a medical urgency requiring prompt attention, as the longer the graft remains clotted, the harder it becomes to restore function.[9]

⚠️ Important
Patients should be taught to check their graft daily by feeling for the thrill. This simple habit, performed each morning upon waking, can detect problems early. If the thrill disappears or changes significantly, or if any redness, warmth, or swelling develops around the graft, contact your dialysis center or doctor immediately. Early detection of stenosis allows for treatment before complete clotting occurs.

Prevention

Preventing graft thrombosis starts with careful evaluation before the graft is even placed. Surgeons should perform preoperative vascular mapping using duplex ultrasound to assess both the arteries and veins that will be used for the graft connections. This testing helps identify blood vessels that are too small, too narrow, or too damaged to function well. When the best possible vessels are chosen from the start, the access has a better chance of lasting longer without complications.[1]

The surgical technique itself matters enormously. The size and angle of the connection between the graft and the vein should be optimized based on the specific anatomy of each patient. Some surgeons aim to create an anastomotic length approximately 1.5 times the diameter of the artery. The angle of connection should generally be kept as acute as feasible, with research suggesting that angles around 30 degrees may offer the best balance between avoiding abnormally high and abnormally low blood flow patterns.[1][20]

After the graft is placed, ongoing monitoring is essential for catching problems before thrombosis occurs. This approach, called surveillance, involves regular checking of the access between dialysis sessions. Physical examination should be performed at least monthly by a trained healthcare provider, but patients can and should examine their own access daily. The “look, feel, and listen” approach helps identify early warning signs. Looking means checking for swelling, skin changes, or visible pulsations. Feeling means checking for the thrill and noting any changes in its strength or quality. Listening with a stethoscope (if available) reveals changes in the bruit that might signal stenosis.[12][13]

Some dialysis centers use more sophisticated monitoring techniques. These may include measuring blood flow rates through the access during dialysis sessions or performing periodic ultrasound examinations to look for narrowing before symptoms develop. While the evidence about whether this type of surveillance actually prevents thrombosis or prolongs access life is mixed, it can identify at-risk grafts that might benefit from preventive treatment.[5][12]

Protecting the graft from unnecessary trauma is crucial. Patients should avoid having blood drawn, intravenous lines placed, or blood pressure measurements taken in the arm with the graft. During dialysis, the staff should rotate needle insertion sites rather than using the same spots repeatedly, which helps prevent scar tissue formation. Between dialysis sessions, patients should avoid heavy lifting with the access arm—generally nothing heavier than about 7 kilograms or 15 pounds. Sleeping on the access arm should be avoided as well.[17][19]

Managing underlying health conditions helps preserve access function. Good control of blood sugar levels in diabetic patients and blood pressure control in all patients can slow the progression of blood vessel disease. Following dietary restrictions recommended for kidney disease may also help, as this can reduce the buildup of waste products that might contribute to blood vessel inflammation and clotting.[19]

Pathophysiology

Understanding what happens inside an arteriovenous graft at the cellular and mechanical level helps explain why thrombosis occurs. When a synthetic graft is connected between an artery and a vein, it creates a dramatic and unnatural change in the body’s circulation. Normally, blood flows from arteries through progressively smaller vessels called capillaries, where nutrients and oxygen are delivered to tissues, and then into veins that return blood to the heart. With an arteriovenous graft, blood bypasses the capillary system entirely, flowing directly from the high-pressure arterial system into the low-pressure venous system.[2][16]

This creates several problems. First, the tissues that would normally receive blood through the bypassed capillaries may not get adequate oxygen and nutrients. Second, and more relevant to thrombosis, the veins suddenly must handle blood flowing at arterial pressures and speeds—something they were never designed to do. Arteries have thick, muscular walls that can withstand high pressure. Veins have thin walls and are meant to carry blood at low pressure and slow speed. When arterial blood suddenly rushes into a vein at high speed and pressure, the vein wall experiences significant mechanical stress and injury.[2]

The inner lining of blood vessels, called the endothelium, is particularly sensitive to changes in blood flow patterns. Endothelial cells can sense when blood is flowing too fast, too slowly, or in abnormal turbulent patterns. When the graft-to-vein connection creates disturbed flow—with swirling eddies, areas of very high speed, or zones where flow nearly stagnates—the endothelial cells become activated and damaged. This triggers an inflammatory response and the activation of the blood clotting system.[1]

In response to this ongoing injury, the body attempts to repair and protect the vessel wall through intimal hyperplasia. Smooth muscle cells from the vessel wall migrate inward and multiply. They produce extra connective tissue proteins that build up in layers. This process is meant to be protective, but it backfires by progressively narrowing the vessel opening. As the stenosis worsens, blood flow becomes even more disturbed, creating a vicious cycle of more injury, more inflammation, and more narrowing.[17]

The repeated needle punctures required for dialysis add another layer of injury. Each time a needle penetrates the graft wall, the body must seal the hole with scar tissue. Over weeks, months, and years, this accumulated scar tissue contributes to stenosis. The trauma from cannulation can also directly damage the vessel lining, accelerating intimal hyperplasia in those areas.[17]

When stenosis reaches a critical degree—usually when the vessel diameter is reduced by more than 50%—blood flow slows dramatically. Slow-moving blood is much more likely to clot than blood flowing at normal speeds. Additionally, the turbulent flow patterns around a stenotic area create zones where platelets and clotting factors accumulate. Platelets are small blood cells that stick together to form clots; when they encounter damaged vessel walls and slow flow, they become activated and begin forming a thrombus. Once a small clot starts, it tends to grow rapidly, eventually blocking the entire graft.[9][5]

The geometry of the graft-to-vein connection affects these flow patterns significantly. Computer simulations of blood flow through grafts have shown that very shallow connection angles create zones of abnormally low shear rate—the rate at which layers of blood slide past each other. Low shear rates allow blood cells to settle and aggregate, promoting clot formation. Conversely, very steep connection angles create zones of abnormally high shear rate, which can directly damage blood cells and the vessel wall. The optimal angle appears to be one that minimizes both extremes, allowing relatively smooth flow transitions.[20]

The material properties of the synthetic graft itself also play a role. The stiff walls of polytetrafluoroethylene grafts do not expand and contract with each heartbeat the way natural arteries do. This mismatch in mechanical properties between the graft and the native vessels it connects to creates additional stress concentrations at the connection points, contributing to intimal hyperplasia and stenosis formation.[1]

Ongoing Clinical Trials on Arteriovenous graft thrombosis

  • Study on MK-2060 for Preventing Blood Clots in Dialysis Patients with End-Stage Kidney Disease

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Germany Greece Italy Portugal +2

References

https://evtoday.com/articles/2018-june-supplement/the-pathophysiology-of-arteriovenous-graft-thrombosis-and-stenosis

https://www.mayoclinic.org/diseases-conditions/arteriovenous-fistula/symptoms-causes/syc-20369567

https://www.radiologyinfo.org/en/info/dialysisfistulagraft

https://pmc.ncbi.nlm.nih.gov/articles/PMC5332078/

https://cdt.amegroups.org/article/view/16884/html

https://emedicine.medscape.com/article/419393-overview

https://pmc.ncbi.nlm.nih.gov/articles/PMC6424380/

https://evtoday.com/articles/2023-june/tips-tricks-and-pitfalls-for-thrombosed-avfs

https://www.radiologyinfo.org/en/info/dialysisfistulagraft

https://pmc.ncbi.nlm.nih.gov/articles/PMC5332078/

https://emedicine.medscape.com/article/419393-overview

https://cdt.amegroups.org/article/view/16884/html

https://evtoday.com/articles/2023-june/tips-tricks-and-pitfalls-for-thrombosed-avfs

https://pmc.ncbi.nlm.nih.gov/articles/PMC5332078/

https://www.cuh.nhs.uk/patient-information/care-of-your-arteriovenous-fistula-avf-after-surgery/

https://www.mayoclinic.org/diseases-conditions/arteriovenous-fistula/symptoms-causes/syc-20369567

https://www.azuravascularcare.com/infodialysisaccess/what-causes-stenosis-in-an-av-fistula/

https://cdt.amegroups.org/article/view/16884/html

https://myhealth.alberta.ca/Health/aftercareinformation/pages/conditions.aspx?hwid=ug4015

https://www.nature.com/articles/s41598-021-90813-3

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

How often does arteriovenous graft thrombosis occur compared to fistula thrombosis?

Arteriovenous grafts clot much more frequently than fistulas. Graft thrombosis happens approximately 0.5 to 2.0 times per patient per year, while arteriovenous fistula thrombosis occurs only 0.1 to 0.5 times per year. This makes grafts four to twenty times more likely to clot than fistulas.

What is the most common cause of graft thrombosis?

Stenosis, or narrowing of the blood vessels, is the number one cause of graft thrombosis. It causes approximately 78% of all early graft failures and remains the most common cause of late failures after three months. Stenosis usually develops at the connection point between the graft and the vein.

Can a thrombosed graft be saved or does it need to be replaced?

Many thrombosed grafts can be saved through procedures called declotting or thrombectomy. These can be done using minimally invasive techniques that remove the clot and treat the underlying stenosis. However, the longer the graft remains clotted, the harder it becomes to restore function, which is why prompt treatment is essential.

What should I do if my graft stops making its normal buzzing feeling?

The disappearance or significant weakening of the thrill (buzzing sensation) in your graft is a warning sign that requires immediate attention. Contact your dialysis center or doctor right away. This could indicate stenosis or early thrombosis, and early treatment can often prevent complete clotting and loss of the access.

Why do patients with diabetes have higher rates of graft thrombosis?

Diabetes damages blood vessels throughout the body, making them less flexible and more prone to narrowing. Diabetic patients often have arteries that are hardened by calcium deposits and cannot dilate properly to provide adequate blood flow through the graft. This increases the risk of stenosis formation and subsequent thrombosis.

🎯 Key takeaways

  • Arteriovenous graft thrombosis affects over 400,000 hemodialysis patients yearly in the United States and is the leading cause of permanent access loss
  • Stenosis causes 78% of early graft failures, making it the primary culprit behind thrombosis events
  • Daily self-monitoring by feeling for the thrill can catch problems early before complete clotting occurs
  • The angle at which the graft connects to the vein significantly impacts blood flow patterns, with 30 degrees being optimal according to computer simulations
  • Grafts clot 4 to 20 times more often than fistulas, occurring 0.5 to 2.0 times per patient per year
  • Protecting your graft from trauma by avoiding heavy lifting, blood draws, and blood pressure measurements in the access arm helps prevent complications
  • Access-related problems account for 25% of hospital admissions among dialysis patients
  • Early treatment of thrombosis through minimally invasive procedures can often save the access, but time is critical

Connected medications: